Ever­est Med­i­cines be­gins pro­duc­tion at its new $129M+ mR­NA vac­cine man­u­fac­tur­ing fa­cil­i­ty in Chi­na

The Chi­na-based biotech Ever­est Med­i­cines has opened the doors to a new man­u­fac­tur­ing fa­cil­i­ty to pro­duce mR­NA-based vac­cines.

Ever­est’s new fa­cil­i­ty, which is lo­cat­ed just to the west of Shang­hai in Ji­ashan, Zhe­jiang Province, is around 58,000 square me­ters, or an es­ti­mat­ed 624,306 square feet, and had an in­vest­ment of more than RMB 900 mil­lion ($129 mil­lion). The man­u­fac­tur­ing fa­cil­i­ty plans to pro­duce around 700 mil­lion dos­es of mR­NA vac­cine an­nu­al­ly.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER